Until FDA warning, thickener used in NICUs without trials

This article looks at how the practice of using a formula and milk thickener to treat infants with difficulty swallowing was adopted without reviews, leading to an FDA warning that it may cause necrotizing enterocolitis. The thickener used a food ingredient that did not need to be reviewed by the FDA since it was on the "generally recognized as safe" list.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA